The effect of entacapone on motor performance in non-fluctuating patients with Parkinson's disease analyzed with computerized movement analysis

被引：0
|
作者：
Mrowka, M
Johnels, B
Bremen, D
Odin, P
机构：
来源：
MOVEMENT DISORDERS | 2002年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P222
引用
收藏
页码：S80 / S80
页数：1
相关论文
共 50 条
  • [21] Effect of opicapone and entacapone on early morning-OFF pattern in Parkinson's disease patients with motor fluctuations
    Videnovic, A.
    Poewe, W.
    Lees, A.
    Ferreira, J.
    Klepitskaya, O.
    Loureiro, R.
    Magalhaes, D.
    Rocha, J. -F.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2020, 35 : S486 - S487
  • [22] EFFECT OF OPICAPONE AND ENTACAPONE ON EARLY MORNING-OFF PATTERN IN PARKINSON'S DISEASE PATIENTS WITH MOTOR FLUCTUATIONS
    Videnovic, A.
    Poewe, W.
    Lees, A.
    Ferreira, J. J.
    Klepitskaya, O.
    Loureiro, R.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    PARKINSONISM & RELATED DISORDERS, 2024, 122
  • [23] Effect of bedtime levodopa/carpidopa/entacapone (Stalevo®) on sleep disturbance in patients with Parkinson's disease with motor fluctuation
    Park, K. W.
    Ryu, H. S.
    Kim, M. S.
    Choi, N. R.
    Chung, S. J.
    MOVEMENT DISORDERS, 2018, 33 : S721 - S722
  • [24] Effect of sleep deprivation on motor performance in patients with Parkinson's disease
    Högl, B
    Peralta, C
    Wetter, TC
    Gershanik, O
    Trenkwalder, C
    MOVEMENT DISORDERS, 2001, 16 (04) : 616 - 621
  • [25] Non motor fluctuations in patients with Parkinson's disease
    Wadia, P. M.
    Barretto, M.
    Lalkaka, J. L.
    Devare, S.
    Dyas, K.
    Singhal, B. S.
    MOVEMENT DISORDERS, 2012, 27 : S315 - S315
  • [26] Stalevo (levodopa/carbidopa/entacapone) provides improved symptom control in fluctuating Parkinson's disease patients comparable to levodopa/DDCI given in combination with entacapone
    Oertel, W
    MOVEMENT DISORDERS, 2004, 19 : S258 - S258
  • [27] Beneficial effect of entacapone on the activities of daily living in nonfluctuating patients with Parkinson's disease
    Brooks, DJ
    Poewe, W
    Deuschl, G
    Kuhltalahti, ER
    Leinonen, M
    Reinikainen, K
    NEUROLOGY, 2001, 56 (08) : A343 - A344
  • [28] Effect of levodopa and entacapone treatment on plasma homocysteine levels in Parkinson's disease patients
    Nevrly, M.
    Kanovsky, P.
    Vranova, H.
    Langova, K.
    Hlustik, P.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 (06) : 477 - 478
  • [29] The effect of COMT inhibition with entacapone on cardiorespiratory responses to exercise in patients with Parkinson's disease
    Lyytinen, J
    Kaakkola, S
    Gordin, A
    Kultalahti, ER
    Teräväinen, H
    Sovijärvi, A
    PARKINSONISM & RELATED DISORDERS, 2002, 8 (05) : 349 - 355
  • [30] Effect of Opicapone on Levodopa Pharmacokinetics in Patients with Fluctuating Parkinson's Disease
    Ferreira, Joaquim J.
    Poewe, Werner
    Rascol, Olivier
    Stocchi, Fabrizio
    Antonini, Angelo
    Moreira, Joana
    Guimaraes, Bruno
    Rocha, Jose-Francisco
    Soares-da-Silva, Patricio
    MOVEMENT DISORDERS, 2022, 37 (11) : 2272 - 2283
12345